Pfizer Licensing, Development & Alliances
Worldwide Pharmaceutical Operations - Regional Business Development

About Us

Worldwide Pharmaceuticals Operations - Regional Business Development (WPO RBD) is a team within the Worldwide Pharmaceutical Operations responsible for regional licensing of late-stage as well as marketed products across Europe, Japan, Asia, Canada, Latin America and Africa/Middle East.

The group is also responsible for out-licensing in these regions as well as support of country business development activities in those regions.

What We Do

Outside Pfizer, we work directly with partners across a vast array of companies who share a common vision and complementary strengths to build winning collaborations and mutually beneficial alliances. We are open to new, creative, faster and better ways of partnership.

Within Pfizer, we work closely with colleagues in Regional Business Operations, Marketing, Medical, Clinical, Regulatory, Manufacturing, Research & Development and other parts of the organization to provide seamless, rapid and comprehensive evaluation of external opportunities.

As a general rule, WPO - Regional Business Development focuses on late stage (Phase 3, pre-registration & registered) opportunities, though we also work on specific Phase 2 opportunities. The licensing activities span specific country opportunities, to regional (e.g. Asia, Europe, etc), to pan regional and ex-US wide opportunities.

How We Do It

Our partnering process has been structured to provide a rapid and comprehensive evaluation of the scientific merits, market potential and commercial viability of all opportunities.

To facilitate initial contact we have established a single gateway for opportunity submission, here.

Through this portal your information is instantly routed to the right WPO Regional Business Development executive for review. This is the fastest way into the team and guarantees that your project will be reviewed by the right people. You will receive an automated response acknowledging that your submission has been received. It will take us 2-4 weeks for us to respond to your submission.

Areas of Interest

We are actively seeking external opportunities for small molecules, compounds with unique patient friendly delivery systems and biologics in several therapeutic areas. Key strategic focus areas:

• Find products that complement our global product portfolio by filling gaps at the local & regional level,
• Identify products that are synergistic and amplify the value of our existing products, and
• Meet unmet medical needs in specific regions e.g. Asia, Africa, etc